Yao‐Jie Pan

452 total citations
17 papers, 319 citations indexed

About

Yao‐Jie Pan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yao‐Jie Pan has authored 17 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yao‐Jie Pan's work include RNA Research and Splicing (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Yao‐Jie Pan is often cited by papers focused on RNA Research and Splicing (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Yao‐Jie Pan collaborates with scholars based in China. Yao‐Jie Pan's co-authors include Dong‐Sheng Pei, Fu‐Chun Huo, Jie Mou, Lulu Wei, Xiaojin Wu, Jian Wan, Junnian Zheng, Ying Zhuang, Wenqi Du and Tongtong Li and has published in prestigious journals such as Scientific Reports, Cell Death and Differentiation and Cell Death and Disease.

In The Last Decade

Yao‐Jie Pan

16 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yao‐Jie Pan China	10	255	190	36	22	21	17	319
Marianna Colamaio Italy	8	282 1.1×	241 1.3×	45 1.3×	25 1.1×	27 1.3×	8	356
Feiye Liu China	9	213 0.8×	148 0.8×	44 1.2×	23 1.0×	19 0.9×	13	294
Peter J. Mullen Canada	3	228 0.9×	88 0.5×	37 1.0×	20 0.9×	19 0.9×	4	290
Yadong Wang China	11	252 1.0×	214 1.1×	50 1.4×	24 1.1×	35 1.7×	16	317
Shuang Chen China	11	326 1.3×	215 1.1×	49 1.4×	23 1.0×	18 0.9×	16	377
Negin Taghehchian Iran	12	248 1.0×	174 0.9×	54 1.5×	29 1.3×	22 1.0×	33	320
Jiali Long China	8	306 1.2×	262 1.4×	34 0.9×	25 1.1×	22 1.0×	12	371
Hong Ren China	10	260 1.0×	162 0.9×	59 1.6×	37 1.7×	26 1.2×	17	309
Chuankui Wei China	11	312 1.2×	271 1.4×	40 1.1×	25 1.1×	25 1.2×	14	397
Evan J. Greenawalt United States	5	234 0.9×	193 1.0×	46 1.3×	25 1.1×	21 1.0×	5	277

Countries citing papers authored by Yao‐Jie Pan

Since Specialization

Citations

This map shows the geographic impact of Yao‐Jie Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao‐Jie Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao‐Jie Pan more than expected).

Fields of papers citing papers by Yao‐Jie Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao‐Jie Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao‐Jie Pan. The network helps show where Yao‐Jie Pan may publish in the future.

Co-authorship network of co-authors of Yao‐Jie Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Yao‐Jie Pan. A scholar is included among the top collaborators of Yao‐Jie Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao‐Jie Pan. Yao‐Jie Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Chen, Xiaochen, et al.. (2025). Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications. Frontiers in Pharmacology. 16. 1598009–1598009. 1 indexed citations

Pan, Yao‐Jie, et al.. (2023). PAK5 potentiates slug transactivation of N-cadherin to facilitate metastasis of renal cell carcinoma. Cellular Signalling. 110. 110803–110803.

Huo, Fu‐Chun, Zhi‐Man Zhu, Wenqi Du, et al.. (2023). HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5. Pharmacological Research. 195. 106863–106863. 13 indexed citations

Liu, Bowen, Jin Wang, Yao‐Jie Pan, et al.. (2023). Long noncoding RNA LINC01594 inhibits the CELF6-mediated splicing of oncogenic CD44 variants to promote colorectal cancer metastasis. Cell Death and Disease. 14(7). 427–427. 8 indexed citations

Pan, Yao‐Jie, Bowen Liu, & Dong‐Sheng Pei. (2022). The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application. DNA and Cell Biology. 41(9). 790–809. 1 indexed citations

Pan, Yao‐Jie, et al.. (2022). Alternative splicing of HSPA12A pre‐RNA by SRSF11 contributes to metastasis potential of colorectal cancer. Clinical and Translational Medicine. 12(11). e1113–e1113. 16 indexed citations

Li, Tongtong, Jie Mou, Yao‐Jie Pan, et al.. (2021). MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway. Journal of Biomedical Science. 28(1). 56–56. 20 indexed citations

Pan, Yao‐Jie, et al.. (2021). An Adaptive Weighted Envelope Based Piecewise Fitting Method for Molding Process Data. 6590–6595. 1 indexed citations

Pan, Yao‐Jie, et al.. (2019). <p>MiR-326: Promising Biomarker for Cancer</p>. Cancer Management and Research. Volume 11. 10411–10418. 46 indexed citations

10.

Huo, Fu‐Chun, Yao‐Jie Pan, Tongtong Li, Jie Mou, & Dong‐Sheng Pei. (2018). PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1. Cell Death and Differentiation. 26(6). 994–1006. 30 indexed citations

11.

Li, Pei‐Hua, et al.. (2018). Suppression of Jab1 expression inhibits proliferation and promotes apoptosis of AMC-HN-8 cells. Oncology Letters. 15(4). 5137–5142. 4 indexed citations

12.

Wu, Jinxia, Wenqi Du, Xiucun Wang, et al.. (2018). Ras‑related protein Rap2c promotes the migration and invasion of human osteosarcoma cells. Oncology Letters. 15(4). 462–462. 19 indexed citations

13.

Pan, Yao‐Jie, Lulu Wei, Xiaojin Wu, et al.. (2017). MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5. Cell Death and Disease. 8(10). e3155–e3155. 68 indexed citations

14.

Wu, Jinxia, Wenqi Du, Lulu Wei, et al.. (2017). Rap2a serves as a potential prognostic indicator of renal cell carcinoma and promotes its migration and invasion through up-regulating p-Akt. Scientific Reports. 7(1). 6623–6623. 17 indexed citations

15.

Zhang, Yingchun, Fu‐Chun Huo, Lulu Wei, et al.. (2017). PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo. Journal of Experimental & Clinical Cancer Research. 36(1). 146–146. 37 indexed citations

16.

Liu, Xu, Yao‐Jie Pan, Junnian Zheng, & Dong‐Sheng Pei. (2016). The Role of Tumor Suppressor DLC-1: Far From Clear. Anti-Cancer Agents in Medicinal Chemistry. 17(7). 896–901. 6 indexed citations

17.

Pan, Yao‐Jie, Ying Zhuang, Junnian Zheng, & Dong‐Sheng Pei. (2016). MiR-106a: Promising biomarker for cancer. Bioorganic & Medicinal Chemistry Letters. 26(22). 5373–5377. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact